Who are the key players in the necrotising enterocolitis market?

Some of the key players are NEC, NEC, Others.

Global Necrotising Enterocolitis Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Necrotising Enterocolitis Market Research Report 2022

Code: QYRE-Auto-20B5977

Report

July 2022

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

NEC

GlaxoSmithKline PLC

Pfizer Inc

Eli Lilly and Company

Bayer HealthCare

Becton Dickinson and Company

Bristol Myers Squibb Company

Medtronic Inc

Necrotising Enterocolitis Market

Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.

The global Necrotising Enterocolitis market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Treatment of Necrotising Enterocolitis consists primarily of supportive care including providing bowel rest by stopping enteral feeds, gastric decompression with intermittent suction, fluid repletion to correct electrolyte abnormalities and third-space losses, support for blood pressure, parenteral nutrition, and prompt antibiotic therapy.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Necrotising Enterocolitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Necrotising Enterocolitis market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Necrotising Enterocolitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Necrotising Enterocolitis market.

Necrotising Enterocolitis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Necrotising Enterocolitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Scope of Necrotising Enterocolitis Market Report

Report Metric	Details
Report Name	Global Necrotising Enterocolitis Market
Base Year	2021
Forecasted years	2022-2028
By Company	GlaxoSmithKline Pfizer Eli Lilly And Company Bayer HealthCare Becton, Dickinson And Company Bristol-Myers Squibb Company Medtronic
Segment by Type	Stage I Stage II Stage III
Segment by Application	Hospital & Clinic Diagnostic Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Necrotising Enterocolitis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Stage I

1.2.3 Stage II

1.2.4 Stage III

1.3 Market by Application

1.3.1 Global Necrotising Enterocolitis Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital & Clinic

1.3.3 Diagnostic Center

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Necrotising Enterocolitis Market Perspective (2017-2028)

2.2 Necrotising Enterocolitis Growth Trends by Region

2.2.1 Necrotising Enterocolitis Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Necrotising Enterocolitis Historic Market Size by Region (2017-2022)

2.2.3 Necrotising Enterocolitis Forecasted Market Size by Region (2023-2028)

2.3 Necrotising Enterocolitis Market Dynamics

2.3.1 Necrotising Enterocolitis Industry Trends

2.3.2 Necrotising Enterocolitis Market Drivers

2.3.3 Necrotising Enterocolitis Market Challenges

2.3.4 Necrotising Enterocolitis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Necrotising Enterocolitis Players by Revenue

3.1.1 Global Top Necrotising Enterocolitis Players by Revenue (2017-2022)

3.1.2 Global Necrotising Enterocolitis Revenue Market Share by Players (2017-2022)

3.2 Global Necrotising Enterocolitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Necrotising Enterocolitis Revenue

3.4 Global Necrotising Enterocolitis Market Concentration Ratio

3.4.1 Global Necrotising Enterocolitis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Necrotising Enterocolitis Revenue in 2021

3.5 Necrotising Enterocolitis Key Players Head office and Area Served

3.6 Key Players Necrotising Enterocolitis Product Solution and Service

3.7 Date of Enter into Necrotising Enterocolitis Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Necrotising Enterocolitis Breakdown Data by Type

4.1 Global Necrotising Enterocolitis Historic Market Size by Type (2017-2022)

4.2 Global Necrotising Enterocolitis Forecasted Market Size by Type (2023-2028)

5 Necrotising Enterocolitis Breakdown Data by Application

5.1 Global Necrotising Enterocolitis Historic Market Size by Application (2017-2022)

5.2 Global Necrotising Enterocolitis Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Necrotising Enterocolitis Market Size (2017-2028)

6.2 North America Necrotising Enterocolitis Market Size by Country (2017-2022)

6.3 North America Necrotising Enterocolitis Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Necrotising Enterocolitis Market Size (2017-2028)

7.2 Europe Necrotising Enterocolitis Market Size by Country (2017-2022)

7.3 Europe Necrotising Enterocolitis Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Necrotising Enterocolitis Market Size (2017-2028)

8.2 Asia-Pacific Necrotising Enterocolitis Market Size by Country (2017-2022)

8.3 Asia-Pacific Necrotising Enterocolitis Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Necrotising Enterocolitis Market Size (2017-2028)

9.2 Latin America Necrotising Enterocolitis Market Size by Country (2017-2022)

9.3 Latin America Necrotising Enterocolitis Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Necrotising Enterocolitis Market Size (2017-2028)

10.2 Middle East & Africa Necrotising Enterocolitis Market Size by Country (2017-2022)

10.3 Middle East & Africa Necrotising Enterocolitis Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Necrotising Enterocolitis Introduction

11.1.4 GlaxoSmithKline Revenue in Necrotising Enterocolitis Business (2017-2022)

11.1.5 GlaxoSmithKline Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Necrotising Enterocolitis Introduction

11.2.4 Pfizer Revenue in Necrotising Enterocolitis Business (2017-2022)

11.2.5 Pfizer Recent Development

11.3 Eli Lilly And Company

11.3.1 Eli Lilly And Company Company Detail

11.3.2 Eli Lilly And Company Business Overview

11.3.3 Eli Lilly And Company Necrotising Enterocolitis Introduction

11.3.4 Eli Lilly And Company Revenue in Necrotising Enterocolitis Business (2017-2022)

11.3.5 Eli Lilly And Company Recent Development

11.4 Bayer HealthCare

11.4.1 Bayer HealthCare Company Detail

11.4.2 Bayer HealthCare Business Overview

11.4.3 Bayer HealthCare Necrotising Enterocolitis Introduction

11.4.4 Bayer HealthCare Revenue in Necrotising Enterocolitis Business (2017-2022)

11.4.5 Bayer HealthCare Recent Development

11.5 Becton, Dickinson And Company

11.5.1 Becton, Dickinson And Company Company Detail

11.5.2 Becton, Dickinson And Company Business Overview

11.5.3 Becton, Dickinson And Company Necrotising Enterocolitis Introduction

11.5.4 Becton, Dickinson And Company Revenue in Necrotising Enterocolitis Business (2017-2022)

11.5.5 Becton, Dickinson And Company Recent Development

11.6 Bristol-Myers Squibb Company

11.6.1 Bristol-Myers Squibb Company Company Detail

11.6.2 Bristol-Myers Squibb Company Business Overview

11.6.3 Bristol-Myers Squibb Company Necrotising Enterocolitis Introduction

11.6.4 Bristol-Myers Squibb Company Revenue in Necrotising Enterocolitis Business (2017-2022)

11.6.5 Bristol-Myers Squibb Company Recent Development

11.7 Medtronic

11.7.1 Medtronic Company Detail

11.7.2 Medtronic Business Overview

11.7.3 Medtronic Necrotising Enterocolitis Introduction

11.7.4 Medtronic Revenue in Necrotising Enterocolitis Business (2017-2022)

11.7.5 Medtronic Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

NEC

GlaxoSmithKline PLC

Pfizer Inc

Eli Lilly and Company

Bayer HealthCare

Becton Dickinson and Company

Bristol Myers Squibb Company

Medtronic Inc

List of Tables

Table 1. Global Necrotising Enterocolitis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

Table 2. Key Players of Stage I

Table 3. Key Players of Stage II

Table 4. Key Players of Stage III

Table 5. Global Necrotising Enterocolitis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Necrotising Enterocolitis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Necrotising Enterocolitis Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Necrotising Enterocolitis Market Share by Region (2017-2022)

Table 9. Global Necrotising Enterocolitis Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Necrotising Enterocolitis Market Share by Region (2023-2028)

Table 11. Necrotising Enterocolitis Market Trends

Table 12. Necrotising Enterocolitis Market Drivers

Table 13. Necrotising Enterocolitis Market Challenges

Table 14. Necrotising Enterocolitis Market Restraints

Table 15. Global Necrotising Enterocolitis Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Necrotising Enterocolitis Market Share by Players (2017-2022)

Table 17. Global Top Necrotising Enterocolitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotising Enterocolitis as of 2021)

Table 18. Ranking of Global Top Necrotising Enterocolitis Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Necrotising Enterocolitis Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Necrotising Enterocolitis Product Solution and Service

Table 22. Date of Enter into Necrotising Enterocolitis Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Necrotising Enterocolitis Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Necrotising Enterocolitis Revenue Market Share by Type (2017-2022)

Table 26. Global Necrotising Enterocolitis Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Necrotising Enterocolitis Revenue Market Share by Type (2023-2028)

Table 28. Global Necrotising Enterocolitis Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Necrotising Enterocolitis Revenue Market Share by Application (2017-2022)

Table 30. Global Necrotising Enterocolitis Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Necrotising Enterocolitis Revenue Market Share by Application (2023-2028)

Table 32. North America Necrotising Enterocolitis Market Size by Country (2017-2022) & (US$ Million)

Table 33. North America Necrotising Enterocolitis Market Size by Country (2023-2028) & (US$ Million)

Table 34. Europe Necrotising Enterocolitis Market Size by Country (2017-2022) & (US$ Million)

Table 35. Europe Necrotising Enterocolitis Market Size by Country (2023-2028) & (US$ Million)

Table 36. Asia-Pacific Necrotising Enterocolitis Market Size by Region (2017-2022) & (US$ Million)

Table 37. Asia-Pacific Necrotising Enterocolitis Market Size by Region (2023-2028) & (US$ Million)

Table 38. Latin America Necrotising Enterocolitis Market Size by Country (2017-2022) & (US$ Million)

Table 39. Latin America Necrotising Enterocolitis Market Size by Country (2023-2028) & (US$ Million)

Table 40. Middle East & Africa Necrotising Enterocolitis Market Size by Country (2017-2022) & (US$ Million)

Table 41. Middle East & Africa Necrotising Enterocolitis Market Size by Country (2023-2028) & (US$ Million)

Table 42. GlaxoSmithKline Company Detail

Table 43. GlaxoSmithKline Business Overview

Table 44. GlaxoSmithKline Necrotising Enterocolitis Product

Table 45. GlaxoSmithKline Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 46. GlaxoSmithKline Recent Development

Table 47. Pfizer Company Detail

Table 48. Pfizer Business Overview

Table 49. Pfizer Necrotising Enterocolitis Product

Table 50. Pfizer Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Eli Lilly And Company Company Detail

Table 53. Eli Lilly And Company Business Overview

Table 54. Eli Lilly And Company Necrotising Enterocolitis Product

Table 55. Eli Lilly And Company Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 56. Eli Lilly And Company Recent Development

Table 57. Bayer HealthCare Company Detail

Table 58. Bayer HealthCare Business Overview

Table 59. Bayer HealthCare Necrotising Enterocolitis Product

Table 60. Bayer HealthCare Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 61. Bayer HealthCare Recent Development

Table 62. Becton, Dickinson And Company Company Detail

Table 63. Becton, Dickinson And Company Business Overview

Table 64. Becton, Dickinson And Company Necrotising Enterocolitis Product

Table 65. Becton, Dickinson And Company Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 66. Becton, Dickinson And Company Recent Development

Table 67. Bristol-Myers Squibb Company Company Detail

Table 68. Bristol-Myers Squibb Company Business Overview

Table 69. Bristol-Myers Squibb Company Necrotising Enterocolitis Product

Table 70. Bristol-Myers Squibb Company Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 71. Bristol-Myers Squibb Company Recent Development

Table 72. Medtronic Company Detail

Table 73. Medtronic Business Overview

Table 74. Medtronic Necrotising Enterocolitis Product

Table 75. Medtronic Revenue in Necrotising Enterocolitis Business (2017-2022) & (US$ Million)

Table 76. Medtronic Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Necrotising Enterocolitis Market Share by Type: 2021 VS 2028

Figure 2. Stage I Features

Figure 3. Stage II Features

Figure 4. Stage III Features

Figure 5. Global Necrotising Enterocolitis Market Share by Application in 2021 & 2028

Figure 6. Hospital & Clinic Case Studies

Figure 7. Diagnostic Center Case Studies

Figure 8. Necrotising Enterocolitis Report Years Considered

Figure 9. Global Necrotising Enterocolitis Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global Necrotising Enterocolitis Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Necrotising Enterocolitis Market Share by Region: 2021 VS 2028

Figure 12. Global Necrotising Enterocolitis Market Share by Players in 2021

Figure 13. Global Top Necrotising Enterocolitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotising Enterocolitis as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by Necrotising Enterocolitis Revenue in 2021

Figure 15. North America Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 16. North America Necrotising Enterocolitis Market Share by Country (2017-2028)

Figure 17. United States Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 18. Canada Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 19. Europe Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Europe Necrotising Enterocolitis Market Share by Country (2017-2028)

Figure 21. Germany Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. France Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. U.K. Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Italy Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Russia Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. Nordic Countries Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. Asia-Pacific Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Asia-Pacific Necrotising Enterocolitis Market Share by Region (2017-2028)

Figure 29. China Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Japan Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. South Korea Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Southeast Asia Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. India Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Australia Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Latin America Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Latin America Necrotising Enterocolitis Market Share by Country (2017-2028)

Figure 37. Mexico Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Brazil Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Middle East & Africa Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Middle East & Africa Necrotising Enterocolitis Market Share by Country (2017-2028)

Figure 41. Turkey Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Saudi Arabia Necrotising Enterocolitis Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. GlaxoSmithKline Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 44. Pfizer Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 45. Eli Lilly And Company Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 46. Bayer HealthCare Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 47. Becton, Dickinson And Company Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 49. Medtronic Revenue Growth Rate in Necrotising Enterocolitis Business (2017-2022)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Necrotising Enterocolitis Market Research Report 2022

Published Date: July 2022

Report Code: QYRE-Auto-20B5977

Global Necrotising Enterocolitis Market Research Report 2022

FEATURED COMPANIES

Necrotising Enterocolitis Market

Scope of Necrotising Enterocolitis Market Report

FEATURED COMPANIES

RELATED REPORTS